ALURD (Allurion Technologies) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ALURD Allurion Technologies Inc ALURD
11 GF Score
Price $4.30
GF Value $10.42
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Allurion Technologies Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

ALURD
11GF Score
Allurion Technologies Inc ALURD
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Allurion Technologies (ALURD) Overvalued in 2026?

Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued. The current stock price of $4.30 is trading 58.7% below its estimated GF Value™ of $10.42. GuruFocus considers Allurion Technologies to be Possible Value Trap.

Key valuation signals for ALURD:

  • Interest Received:
  • GF Value™: $10.42 vs. price of $4.30 (58.7% below fair value)
  • GF Score™: 11/100 with 4 warning signs

No single metric tells the full story. See the ALURD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allurion Technologies Business Description

Address 11 Huron Drive, Natick, MA, USA, 01760
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
11GF Score

Get the complete analysis for ALURD

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.30
Price
$10.42
GF Value